1. Home
  2. PTCT

PTCT

PTC Therapeutics Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-12-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

PTC Therapeutics Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of orally administered, small-molecule therapeutics. Its target area is RNA biology post-transcriptional control processes of the events occurring in a cell when an RNA messenger is copied from DNA during the transcription process. The discovered products address multiple therapeutic areas, including rare disorders, such as nonsense mutations in Duchenne muscular dystrophy and oncology.

Founded: 1998 Country:
United States
United States
Employees: N/A City: SOUTH PLAINFIELD
Market Cap: 2.1B IPO Year: 2013
Target Price: $33.62 AVG Volume (30 days): 928.6K
Analyst Decision: Hold Number of Analysts: 14
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -8.37 EPS Growth: N/A
52 Week Low/High: $17.53 - $59.84 Next Earning Date: 04-25-2024
Revenue: $937,822,000 Revenue Growth: 34.20%
Revenue Growth (this year): -34.45% Revenue Growth (next year): 0.32%

Share on Social Networks: